权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

New York Regional Inborn Errors of Immunity Resource Initiative League (NY-ROYAL)

纽约地区先天性缺陷免疫资源倡议联盟 (NY-ROYAL)

基本信息

批准号：
10554965
负责人：
Dusan Bogunovic
金额：
$ 87.29万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-01 至 2028-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10554965
关键词：
Affect Artificial Intelligence Back Bioinformatics Biological Biological Assay Blood specimen Bone Marrow Involvement Bone Marrow Transplantation Candidate Disease Gene Caring Classification Clinical Collaborations Consent DNA Data Databases Defect Diagnosis Diagnostic Disease Educational process of instructing Evaluation Future Genes Genetic Genetic Counseling Genetic Databases Genetic Diseases Genetic Variation Genomics Genotype Hereditary Disease High-Throughput Nucleotide Sequencing Immune System Diseases Immunity Immunologics Immunology Individual Insurance Laboratory Research Machine Learning Medicine New York Patients Phenotype Physicians Population Prevalence Price Process Production Provider Publications Recommendation Reporting Research Resources Review Committee Scientist Time Tissue Sample Triage Validation Variant Work causal variant central database clinical care clinically relevant clinically significant cohort data submission feeding functional outcomes gene discovery gene therapy genetic analysis genetic disorder diagnosis genetic variant genome sequencing multidisciplinary novel precision medicine provider portal systematic review variant of unknown significance web portal

项目摘要

Project Summary Inborn errors of immunity (IEI) are disorders of the immune system which are individually rare but collectively affect 1 in 10,000 individuals. Definitive genetic diagnosis is of essence for timely genetic counseling and clinical care. Such care may involve bone marrow transplantation, gene therapy or precision pharmacotherapeutics, all of which can be curative. The recent advancement of genome sequencing in quality and price has led to an increased rate of discovery of what are now over 400 causal genes underlying IEIs. However, about three quarters of IEI sequencing yields either variants of unknown significance (VUSs) in one of the 400+ genes or require discovery of novel causes. This leads to delays in diagnosis and treatment, especially since most of these VUSs cannot be validated using clinically available assays. As sequencing panels are increasingly utilized and being covered by insurance, the rate of genetic data production outpaces indiividuals’ capacity to interpret it. The primary purpose of this proposal is to build a regional resource which would formalize case review process, match providers and their patients carrying VUSs with research laboratories capable of targeted functional evaluation and/or bioinformatic assessment, thereby leading to VUS reclassification, diagnosis and treatment. It also will infuse research enterprises with clinically significant biological questions. We propose to streamline this process in the NY region by building a 1) patient referral platform and database where providers will be able to input deidentified patient clinical information alongside the associated genetic data (IEI gene panels, WES, and WGS sequencing), 2) a multidisciplinary review process where submitted data will be evaluated by an expert review panel at the forefront of IEI gene discovery and functional validation on a regular basis who will work to disposition relevant VUSs for 3) functional characterization by a collaborating expert team followed by 4) result reporting, VUS reclassification and its inclusion in the national clinically relevant genetic variation database. This multidisciplinary diagnostic NY regional immunology resource is key to supporting the discovery and functional characterization of novel IEI associated genetic variants. This resource will serve future, more broadly applied integration of genomics, artificial intelligence/machine learning, rapid functional assessment and precision medicine.

项目总结